Full 2L QBank
Pharmacology General ccc1cd27

All of the following statements about the use of spironolactone in CHF are true except:

A
It should be administered in low doses to prevent hyperkalemia
B
It affords prognostic benefit in severe heart failure over and above that afforded by ACE inhibitors
C
It helps to overcome the refractoriness to thiazides
D
It affords rapid symptomatic relief in CHF patients
High-Yield Explanation
Loop diuretics are used to provide rapid symptomatic relief whereas aldosterone antagonists decrease the mortality by reversing myocardial remodelling.

Related Pharmacology MCQs

Practice 2,00,000+ NEET PG Questions Free

Timed mock tests, mistake queue analytics, audio lectures & zero attempt limits on i❤️Exams.

Start Free Mock Test Now